Compare · NBSE vs SACH
NBSE vs SACH
Side-by-side comparison of NeuBase Therapeutics Inc. (NBSE) and Sachem Capital Corp. (SACH): market cap, price performance, sector, and recent activity on the wire.
Summary
- NBSE operates in Health Care, while SACH operates in Real Estate - the two are in different parts of the market.
- SACH is the larger of the two at $57.1M, about 1.3x NBSE ($44.8M).
- SACH has hit the wire 11 times in the past 4 weeks while NBSE has been quiet.
- SACH has more recent analyst coverage (5 ratings vs 0 for NBSE).
- Company
- NeuBase Therapeutics Inc.
- Sachem Capital Corp.
- Price
- -
- -
- Market cap
- $44.8M
- $57.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Pharmaceutical Preparations
- Real Estate Investment Trusts
- Exchange
- NASDAQ
- AMEX
- IPO
- 2017
- News (4w)
- 0
- 11
- Recent ratings
- 0
- 5
NeuBase Therapeutics Inc.
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders and cancer. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; and NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
Sachem Capital Corp.
Sachem Capital Corp. operates as a real estate finance company. The company is involved in the originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located primarily in Connecticut. It offers loans to real estate investors to fund their acquisition, renovation, rehabilitation, development, and/or improvement of residential or commercial properties. The company has elected to be taxed as a real estate investment trust (REIT) and would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Sachem Capital Corp. was founded in 2010 and is based in Branford, Connecticut.
Latest NBSE
- NeuBase Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form DEFA14A filed by NeuBase Therapeutics Inc.
- NeuBase Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- SEC Form DEFA14A filed by NeuBase Therapeutics Inc.
- 12 Health Care Stocks Moving In Friday's After-Market Session
- NeuBase Therapeutics Expects Trading In Co's Common Stock Will Be Suspended Upon Opening Of Business On May 13
- On May 2, Nasdaq Notified NeuBase Therapeutics Inc That It Has Not Regained Compliance With Minimum Bid Price Requirement
- NeuBase Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- 12 Health Care Stocks Moving In Friday's After-Market Session
Latest SACH
- Sachem Capital Mourns the Passing of Board Member Arthur Goldberg
- SEC Form DEFA14A filed by Sachem Capital Corp.
- Sachem Capital Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Sachem Capital Reports First Quarter 2026 Results
- SEC Form 10-Q filed by Sachem Capital Corp.
- SEC Form DEFA14A filed by Sachem Capital Corp.
- SEC Form NT 10-Q filed by Sachem Capital Corp.
- SEC Form DEFA14A filed by Sachem Capital Corp.
- Sachem Capital Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
- Sachem Capital Corp. and Industrial Realty Group Announce Strategic Combination to Create IRG Realty Trust, a Top-10 Public Industrial REIT